Moreover additional comparisons of differences in the expression of these 18 genes performed in other human tumor subtypes [RET(+) PTCs and RAS(+) PTCs compared to healthy thyroids] indicated that only few of these genes showed the trend observed in BRAF(+) tumors. The gene discussed is RET; the disease is neoplasm.